Mark G Foletta is Director of DEXCOM INC. Currently has a direct ownership of 2,973 shares of DXCM, which is worth approximately $205,285. The most recent transaction as insider was on May 22, 2024, when has been sold 2,973 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.97K
0% 3M change
10.07% 12M change
Total Value Held $205,285

MARK G FOLETTA Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 22 2024
BUY
Grant, award, or other acquisition
-
2,973 Added 50.0%
2,973 Common Stock
May 18 2024
SELL
Bona fide gift
-
3,306 Reduced 100.0%
0 Common Stock
May 18 2023
SELL
Bona fide gift
-
4,488 Reduced 57.58%
3,306 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
-
3,306 Added 29.78%
7,794 Common Stock
May 20 2022
BUY
Grant, award, or other acquisition
-
1,122 Added 50.0%
1,122 Common Stock
May 19 2022
SELL
Other acquisition or disposition
-
1,054 Reduced 100.0%
0 Common Stock
May 21 2021
BUY
Grant, award, or other acquisition
-
1,054 Added 50.0%
1,054 Common Stock
May 20 2021
SELL
Other acquisition or disposition
-
895 Reduced 100.0%
0 Common Stock

Also insider at

ENTA
ENANTA PHARMACEUTICALS INC Healthcare
AMN
AMN HEALTHCARE SERVICES INC Healthcare
MGF

Mark G Foletta

Director
San Diego, CA

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Track Activities on DXCM